2,103views

test

00:00 / 00:00

Psychiatric emergencies: Pathology review

End of Rotation™ exam review

Cardiovascular

Anatomy clinical correlates: Heart
Anatomy clinical correlates: Mediastinum
Aortic dissections and aneurysms: Pathology review
Coronary artery disease: Pathology review
Endocarditis: Pathology review
Heart blocks: Pathology review
Hypertension: Pathology review
Peripheral artery disease: Pathology review
Shock: Pathology review
Supraventricular arrhythmias: Pathology review
Valvular heart disease: Pathology review
Ventricular arrhythmias: Pathology review
Abdominal aortic aneurysm: Clinical sciences
Acute coronary syndrome: Clinical sciences
Acute limb ischemia: Clinical sciences
Aortic dissection: Clinical sciences
Aortic stenosis: Clinical sciences
Approach to bradycardia: Clinical sciences
Approach to chest pain: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to hypertension: Clinical sciences
Approach to shock (pediatrics): Clinical sciences
Approach to shock: Clinical sciences
Approach to syncope: Clinical sciences
Approach to tachycardia: Clinical sciences
Approach to trauma (pediatrics): Clinical sciences
Atrial fibrillation and atrial flutter: Clinical sciences
Atrioventricular block: Clinical sciences
Cardiac tamponade: Clinical sciences
Congestive heart failure: Clinical sciences
Coronary artery disease: Clinical sciences
Deep vein thrombosis: Clinical sciences
Hypovolemic shock: Clinical sciences
Infectious endocarditis: Clinical sciences
Mitral stenosis: Clinical sciences
ACE inhibitors, ARBs and direct renin inhibitors
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Adrenergic antagonists: Presynaptic
Calcium channel blockers
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Lipid-lowering medications: Fibrates
Lipid-lowering medications: Statins
Miscellaneous lipid-lowering medications
Muscarinic antagonists
Positive inotropic medications
Sympatholytics: Alpha-2 agonists
Sympathomimetics: Direct agonists
Thiazide and thiazide-like diuretics

ENOT and ophthalmology

Anatomy clinical correlates: Skull, face and scalp
Anatomy clinical correlates: Temporal regions, oral cavity and nose
Anatomy clinical correlates: Eye
Anatomy clinical correlates: Ear
Anatomy clinical correlates: Vessels, nerves and lymphatics of the neck
Anatomy clinical correlates: Viscera of the neck
Anatomy clinical correlates: Olfactory (CN I) and optic (CN II) nerves
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy clinical correlates: Trigeminal nerve (CN V)
Anatomy clinical correlates: Facial (CN VII) and vestibulocochlear (CN VIII) nerves
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Vertigo: Pathology review
Allergic rhinitis: Clinical sciences
Approach to a red eye: Clinical sciences
Approach to acute vision loss: Clinical sciences
Approach to diplopia: Clinical sciences
Conjunctival disorders: Clinical sciences
Croup and epiglottitis: Clinical sciences
Eyelid disorders: Clinical sciences
Foreign body aspiration and ingestion (pediatrics): Clinical sciences
Glaucoma: Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Periorbital and orbital cellulitis (pediatrics): Clinical sciences
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Upper respiratory tract infections: Clinical sciences
Antihistamines for allergies

Gastrointestinal and nutritional

Anatomy clinical correlates: Anterior and posterior abdominal wall
Anatomy clinical correlates: Inguinal region
Anatomy clinical correlates: Peritoneum and diaphragm
Anatomy clinical correlates: Viscera of the gastrointestinal tract
Anatomy clinical correlates: Other abdominal organs
Appendicitis: Pathology review
Cirrhosis: Pathology review
Diverticular disease: Pathology review
Esophageal disorders: Pathology review
Gallbladder disorders: Pathology review
Gastrointestinal bleeding: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Inflammatory bowel disease: Pathology review
Jaundice: Pathology review
Malabsorption syndromes: Pathology review
Pancreatitis: Pathology review
Viral hepatitis: Pathology review
Adenovirus
Cytomegalovirus
Norovirus
Rotavirus
Bacillus cereus (Food poisoning)
Campylobacter jejuni
Clostridium difficile (Pseudomembranous colitis)
Clostridium perfringens
Escherichia coli
Salmonella (non-typhoidal)
Shigella
Staphylococcus aureus
Vibrio cholerae (Cholera)
Yersinia enterocolitica
Cryptosporidium
Entamoeba histolytica (Amebiasis)
Giardia lamblia
Acute mesenteric ischemia: Clinical sciences
Gastroesophageal reflux disease (pediatrics): Clinical sciences
Diverticulitis: Clinical sciences
Approach to medication exposure (pediatrics): Clinical sciences
Gastroesophageal varices: Clinical sciences
Dehydration (pediatrics): Clinical sciences
Approach to melena and hematemesis (pediatrics): Clinical sciences
Acute pancreatitis: Clinical sciences
Approach to melena and hematemesis: Clinical sciences
Hemorrhoids: Clinical sciences
Esophagitis: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Alcohol-induced hepatitis: Clinical sciences
Femoral hernias: Clinical sciences
Hepatitis A and E: Clinical sciences
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Anal fissure: Clinical sciences
Hepatitis B: Clinical sciences
Gastritis: Clinical sciences
Approach to postoperative abdominal pain: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Hepatitis C: Clinical sciences
Appendicitis: Clinical sciences
Approach to abdominal wall and groin masses: Clinical sciences
Approach to the acute abdomen (pediatrics): Clinical sciences
Infectious gastroenteritis (acute) (pediatrics): Clinical sciences
Approach to upper abdominal pain: Clinical sciences
Approach to acute abdominal pain (pediatrics): Clinical sciences
Infectious gastroenteritis (subacute) (pediatrics): Clinical sciences
Approach to ascites: Clinical sciences
Infectious gastroenteritis: Clinical sciences
Approach to vomiting (acute): Clinical sciences
Approach to biliary colic: Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Approach to vomiting (chronic): Clinical sciences
Approach to vomiting (pediatrics): Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Approach to constipation (pediatrics): Clinical sciences
Cholecystitis: Clinical sciences
Inguinal hernias: Clinical sciences
Approach to constipation: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Ischemic colitis: Clinical sciences
Approach to chronic abdominal pain (pediatrics): Clinical sciences
Chronic mesenteric ischemia: Clinical sciences
Large bowel obstruction: Clinical sciences
Approach to diarrhea (chronic): Clinical sciences
Cirrhosis: Clinical sciences
Mallory-Weiss syndrome: Clinical sciences
Approach to diarrhea (pediatrics): Clinical sciences
Peptic ulcer disease: Clinical sciences
Clostridioides difficile infection: Clinical sciences
Approach to hematochezia (pediatrics): Clinical sciences
Approach to hematochezia: Clinical sciences
Colonic volvulus: Clinical sciences
Peptic ulcers, gastritis, and duodenitis (pediatrics): Clinical sciences
Perianal abscess and fistula: Clinical sciences
Approach to household substance exposure (pediatrics): Clinical sciences
Small bowel obstruction: Clinical sciences
Approach to jaundice (conjugated hyperbilirubinemia): Clinical sciences
Spontaneous bacterial peritonitis: Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Approach to jaundice (unconjugated hyperbilirubinemia): Clinical sciences
Umbilical hernias: Clinical sciences
Ventral and incisional hernias: Clinical sciences
Acid reducing medications
Antidiarrheals
Laxatives and cathartics

Neurology

Anatomy clinical correlates: Cerebral hemispheres
Anatomy clinical correlates: Cerebellum and brainstem
Anatomy clinical correlates: Anterior blood supply to the brain
Anatomy clinical correlates: Posterior blood supply to the brain
Anatomy clinical correlates: Olfactory (CN I) and optic (CN II) nerves
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy clinical correlates: Trigeminal nerve (CN V)
Anatomy clinical correlates: Facial (CN VII) and vestibulocochlear (CN VIII) nerves
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Spinal cord pathways
Anatomy clinical correlates: Vertebral canal
Amnesia, dissociative disorders and delirium: Pathology review
Central nervous system infections: Pathology review
Cerebral vascular disease: Pathology review
Dementia: Pathology review
Demyelinating disorders: Pathology review
Headaches: Pathology review
Neuromuscular junction disorders: Pathology review
Seizures: Pathology review
Traumatic brain injury: Pathology review
Vertigo: Pathology review
Acute stroke (ischemic or hemorrhagic) or TIA: Clinical sciences
Approach to a first unprovoked seizure (pediatrics): Clinical sciences
Approach to altered mental status (pediatrics): Clinical sciences
Approach to altered mental status: Clinical sciences
Approach to blunt cerebrovascular injury: Clinical sciences
Approach to convulsive status epilepticus: Clinical sciences
Approach to differentiating lesions (motor neuron): Clinical sciences
Approach to differentiating lesions (nerve root, plexus, and peripheral nerve): Clinical sciences
Approach to dizziness and vertigo: Clinical sciences
Approach to encephalitis: Clinical sciences
Approach to encephalopathy (acute and subacute): Clinical sciences
Approach to epilepsy: Clinical sciences
Approach to facial palsy: Clinical sciences
Approach to headache or facial pain: Clinical sciences
Approach to household substance exposure (pediatrics): Clinical sciences
Approach to increased intracranial pressure: Clinical sciences
Approach to syncope: Clinical sciences
Approach to trauma (pediatrics): Clinical sciences
Approach to traumatic brain injury (pediatrics): Clinical sciences
Approach to traumatic brain injury: Clinical sciences
Approach to unsteadiness, gait disturbance, or falls: Clinical sciences
Approach to weakness (focal and generalized): Clinical sciences
Guillain-Barré syndrome: Clinical sciences
Meningitis and brain abscess: Clinical sciences
Meningitis (pediatrics): Clinical sciences
Multiple sclerosis: Clinical sciences
Primary headaches (tension, migraine, and cluster): Clinical sciences
Subarachnoid hemorrhage: Clinical sciences
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Antiplatelet medications
General anesthetics
Local anesthetics
Migraine medications
Neuromuscular blockers
Nonbenzodiazepine anticonvulsants
Osmotic diuretics
Thrombolytics

Obstetrics and gynecology

Anatomy clinical correlates: Breast
Anatomy clinical correlates: Female pelvis and perineum
Amenorrhea: Pathology review
Benign breast conditions: Pathology review
Complications during pregnancy: Pathology review
Ovarian cysts and tumors: Pathology review
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review
Sexually transmitted infections: Warts and ulcers: Pathology review
Uterine disorders: Pathology review
Vaginal and vulvar disorders: Pathology review
Adenomyosis: Clinical sciences
Adnexal torsion: Clinical sciences
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Approach to adnexal masses: Clinical sciences
Approach to breast pain (mastalgia): Clinical sciences
Approach to chronic pelvic pain (GYN): Clinical sciences
Approach to first trimester bleeding: Clinical sciences
Approach to postmenopausal bleeding: Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Approach to secondary amenorrhea: Clinical sciences
Approach to third trimester bleeding: Clinical sciences
Approach to vaginal discharge: Clinical sciences
Bacterial vaginosis: Clinical sciences
Breast abscess: Clinical sciences
Chlamydia trachomatis infection: Clinical sciences
Early pregnancy loss: Clinical sciences
Ectopic pregnancy: Clinical sciences
Endometriosis: Clinical sciences
Mastitis: Clinical sciences
Neisseria gonorrhoeae infection: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Placenta previa and vasa previa: Clinical sciences
Placental abruption: Clinical sciences
Prelabor rupture of membranes: Clinical sciences
Preterm labor: Clinical sciences
Primary dysmenorrhea: Clinical sciences
Vaginal trichomoniasis: Clinical sciences
Vulvovaginal candidiasis: Clinical sciences
Aromatase inhibitors
Estrogens and antiestrogens
Progestins and antiprogestins
Uterine stimulants and relaxants

Psychiatry (behavioral medicine)

Amnesia, dissociative disorders and delirium: Pathology review
Anxiety disorders, phobias and stress-related disorders: Pathology Review
Dementia: Pathology review
Drug misuse, intoxication and withdrawal: Alcohol: Pathology review
Drug misuse, intoxication and withdrawal: Hallucinogens: Pathology review
Drug misuse, intoxication and withdrawal: Other depressants: Pathology review
Drug misuse, intoxication and withdrawal: Stimulants: Pathology review
Malingering, factitious disorders and somatoform disorders: Pathology review
Mood disorders: Pathology review
Psychiatric emergencies: Pathology review
Trauma- and stress-related disorders: Pathology review
Alcohol use disorder: Clinical sciences
Alcohol withdrawal: Clinical sciences
Approach to anxiety disorders: Clinical sciences
Approach to mood disorders: Clinical sciences
Approach to schizophrenia spectrum and other psychotic disorders: Clinical sciences
Delirium: Clinical sciences
Generalized anxiety disorder, agoraphobia, and panic disorder: Clinical sciences
Intimate partner violence and sexual assault: Clinical sciences
Non-accidental trauma and neglect (pediatrics): Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Opioid use disorder: Clinical sciences
Opioid withdrawal syndrome: Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Substance use disorder: Clinical sciences
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Atypical antidepressants
Atypical antipsychotics
Lithium
Monoamine oxidase inhibitors
Nonbenzodiazepine anticonvulsants
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid antagonists
Psychomotor stimulants
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Typical antipsychotics

Pulmonology

Anatomy clinical correlates: Pleura and lungs
Anatomy clinical correlates: Thoracic wall
Deep vein thrombosis and pulmonary embolism: Pathology review
Lung cancer and mesothelioma: Pathology review
Obstructive lung diseases: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Pneumonia: Pathology review
Respiratory distress syndrome: Pathology review
Tuberculosis: Pathology review
Acute respiratory distress syndrome: Clinical sciences
Airway obstruction: Clinical sciences
Approach to a cough (acute): Clinical sciences
Approach to a cough (pediatrics): Clinical sciences
Approach to a cough (subacute and chronic): Clinical sciences
Approach to chest pain: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to household substance exposure (pediatrics): Clinical sciences
Approach to trauma (pediatrics): Clinical sciences
Aspiration pneumonia and pneumonitis: Clinical sciences
Asthma: Clinical sciences
Bronchiolitis: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Croup and epiglottitis: Clinical sciences
Foreign body aspiration and ingestion (pediatrics): Clinical sciences
Hospital-acquired and ventilator-associated pneumonia: Clinical sciences
Influenza: Clinical sciences
Lung cancer: Clinical sciences
Pleural effusion: Clinical sciences
Pneumothorax: Clinical sciences
Pulmonary embolism: Clinical sciences
Respiratory failure (pediatrics): Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Tuberculosis (pulmonary): Clinical sciences
Upper respiratory tract infections: Clinical sciences
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors

Urology and renal

Anatomy clinical correlates: Female pelvis and perineum
Anatomy clinical correlates: Male pelvis and perineum
Anatomy clinical correlates: Other abdominal organs
Acid-base disturbances: Pathology review
Electrolyte disturbances: Pathology review
Kidney stones: Pathology review
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Penile conditions: Pathology review
Prostate disorders and cancer: Pathology review
Renal and urinary tract masses: Pathology review
Renal failure: Pathology review
Testicular and scrotal conditions: Pathology review
Urinary incontinence: Pathology review
Urinary tract infections: Pathology review
Approach to acid-base disorders: Clinical sciences
Approach to dysuria: Clinical sciences
Approach to acute kidney injury: Clinical sciences
Approach to hematuria (pediatrics): Clinical sciences
Approach to hypercalcemia: Clinical sciences
Approach to hyperkalemia: Clinical sciences
Approach to hypernatremia (pediatrics): Clinical sciences
Approach to hypernatremia: Clinical sciences
Approach to hypocalcemia (pediatrics): Clinical sciences
Approach to hypocalcemia: Clinical sciences
Approach to hypokalemia: Clinical sciences
Approach to hyponatremia (pediatrics): Clinical sciences
Approach to hyponatremia: Clinical sciences
Approach to metabolic acidosis: Clinical sciences
Approach to metabolic alkalosis: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Approach to respiratory acidosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Approach to trauma (pediatrics): Clinical sciences
Approach to urinary incontinence (GYN): Clinical sciences
Femoral hernias: Clinical sciences
Inguinal hernias: Clinical sciences
Intrinsic acute kidney injury (glomerular causes): Clinical sciences
Intrinsic acute kidney injury (non-glomerular causes): Clinical sciences
Lower urinary tract infection: Clinical sciences
Neisseria gonorrhoeae infection: Clinical sciences
Nephritic syndromes (pediatrics): Clinical sciences
Nephrolithiasis: Clinical sciences
Postrenal acute kidney injury: Clinical sciences
Prerenal acute kidney injury: Clinical sciences
Pyelonephritis: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences
Urinary retention: Clinical sciences
ACE inhibitors, ARBs and direct renin inhibitors
Adrenergic antagonists: Alpha blockers
Androgens and antiandrogens
Carbonic anhydrase inhibitors
Loop diuretics
Osmotic diuretics
PDE5 inhibitors
Potassium sparing diuretics
Thiazide and thiazide-like diuretics

Assessments

USMLE® Step 1 questions

0 / 3 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 3 complete

A 55-year-old woman comes to the emergency department (ED) for evaluation of recurrent left flank pain and vomiting. She has a history of recurrent nephrolithiasis and recently noticed gross blood in her urine. Medical history is notable for obesity, hypertension, hyperlipidemia, depression, and type II diabetes mellitus. The patient has been taking ondansetron at home for nausea as well as losartan, metformin, rosuvastatin, and sertraline for her other medical conditions. On physical exam, the patient has left costovertebral angle tenderness. Blood is detected on urinalysis. The patient's symptoms are well controlled during the ED visit, and she is subsequently discharged with prescription analgesia, additional antiemetics, and urology follow-up. Three days later, the patient is brought back to the ED altered, diaphoretic, and agitated. Temperature is 39.4°C (103°F), pulse is 122/min, respirations are 20/min, and blood pressure is 184/95 mmHg. She has bilateral mydriasis and myoclonus. Which of the following medications was the most likely precipitant of this patient's clinical presentation?

Transcript

Watch video only

A 53 year old male named Noah is brought to the emergency department by his son, who found him with an empty bottle of fluoxetine in his hand. His son mentions that Noah was recently diagnosed with depressive disorder. Upon physical examination, you realize that Noah has a body temperature of 38.9 degrees Celsius, or 102.02 degrees Fahrenheit, and a blood pressure of 162 over 95 millimeters of mercury. In addition, Noah’s pupils appear dilated, and his muscles are very stiff. Finally, neurological examination reveals that Noah has overactive reflexes. Later that day, a 34 year old female named Amelia is brought to the emergency department by her husband. He explains that Amelia has a medical history of schizophrenia, and a few days back she took multiple doses of haloperidol. Upon physical examination, Amelia’s body temperature is 38.7 degrees Celsius or 101.66 degrees Fahrenheit, and her blood pressure is 170 over 100 millimeters of mercury. Similarly to Noah, Amelia has muscle stiffness, but neurological examination reveals diminished reflexes.

All right, now, both Noah and Amelia seem to have some form of psychiatric emergency, which is when a psychiatric condition becomes life-threatening and requires prompt treatment. For your exams, some high yield psychiatric emergencies include suicide attempts, serotonin syndrome, acute dystonia, neuroleptic malignant syndrome, tyramine-induced hypertensive crisis, and delirium tremens.

Now, a very relevant psychiatric emergency, not only for your exams, are suicide attempts. Suicide is when someone takes their own life intentionally. Now, many suicide attempts can be prevented by keeping an eye out for red flags or risk factors, which can be easily remembered with the memory trick SAD PERSONS. The first S here stands for sex, as suicide tends to be more common among males. Next, A stands for age, so remember that suicide is more common among young adults and the elderly. For your exams, you should know that suicide is the second leading cause of death among individuals aged 15 to 34 in the USA, behind motor vehicle crashes. D is for depressive disorder, which is a psychiatric disorder that causes a persistent feeling of sadness, associated with a loss of interest in everyday activities like hobbies. Then P stands for previous suicide attempts, which remember is the most important risk factor for suicide. E stands for excessive alcohol or substance abuse, which causes individuals to be more impulsive, taking risks they normally wouldn’t take like driving recklessly. Oftentimes, alcohol or substance abuse occur together with depression. In fact, many people who experience depression turn to alcohol or substances to temporarily numb their feelings. And vice versa, chronic alcohol or substance abuse can ultimately cause depression, creating a vicious cycle. R is for rational thinking loss in psychosis, a severe mental disorder that can impair thought and emotions, to the point where individuals lose touch with reality. The next S is for sickness, which refers to chronic nonpsychiatric diseases, like end-stage cancer, that can be very hard to deal with. O stands for organized plan, which is when the individual has a specific method for suicide in mind. What’s very important to remember is that the most common method involves firearms like guns. For that reason, it’s key to evaluate if the individual has access to firearms. Next, N stands for no social support, meaning that they have no friends or family to turn to during vulnerable times. The last S refers to stated future intent, which is when a person expresses their suicidal thoughts or intentions.

Now, even if there are no risk factors for suicide, some people may impulsively take their lives in a moment of overwhelming life stress. This could be due to the loss of a loved one, going through a financial crisis, or experiencing various social pressures. Because of that, it’s just as important to focus on protective factors that can reduce the potential for suicidal behavior. Protective factors can include helping individuals develop self-esteem and coping skills. In addition, having cultural and religious beliefs, as well as a sense of purpose in life can discourage suicide. Finally, a key protective factor is companionship and emotional support.

If you suspect that someone’s at risk for attempting suicide, the first thing you should do is evaluate how serious the threat is, and suggest that they seek for help or be hospitalized voluntarily. If they refuse to get help, and they’re an imminent threat, they should be hospitalized involuntarily.

The next high yield psychiatric emergency is serotonin syndrome. Now, serotonin, also called 5-hydroxytryptamine or 5-HT for short, is a neurotransmitter that mainly helps regulate mood and emotions. Presynaptic serotonergic neurons synthesize serotonin and store it in small vesicles. When an action potential reaches the presynaptic membrane, the vesicles fuse with the membrane and release the serotonin into the synaptic cleft. The free serotonin then binds to serotonin or 5HT receptors on the postsynaptic neuron, causing it to fire off its own action potential. The presynaptic membrane also has serotonin reuptake transporters or SERTs, which take serotonin back into the presynaptic neuron, so the postsynaptic neuron stops firing. Inside the presynaptic neuron, some of this serotonin is packed into pre-existing vesicles, waiting to be released once more, while the rest of the serotonin is broken down by mitochondrial enzymes called monoamine oxidases or MAOs for short.

Okay, now, serotonin syndrome is a potentially life-threatening condition caused by high levels of serotonin in the brain. For your tests, remember that most cases of serotonin syndrome occur in people taking psychiatric medications to treat depression, which can be classified as typical and atypical antidepressants. Typical antidepressants include medications that block serotonin reuptake transporters, such as selective serotonin reuptake inhibitors or SSRIs like fluoxetine, serotonin norepinephrine reuptake inhibitors or SNRIs like duloxetine, and tricyclic antidepressants or TCAs like amitriptyline. Typical antidepressants also include medications called monoamine oxidase inhibitors or MAOIs for short, which inhibit the breakdown of serotonin by monoamine oxidases. What’s very high yield is that serotonin syndrome is most likely to occur when MAOIs are taken in combination with another antidepressant medication! Now, some atypical antidepressants, such as vilazodone and vortioxetine, can also cause serotonin syndrome by blocking serotonin reuptake inhibitors. Another important psychiatric medication that can cause serotonin syndrome is buspirone, which is mainly used to treat anxiety disorders. What buspirone does is it binds to serotonin receptors on the postsynaptic membrane and activates them, thereby potentiating the effect of serotonin in the central nervous system.

Now, it’s important to note that serotonin syndrome can also be caused by some nonpsychiatric medications, which you can remember using the mnemonic: The LOSt MD Took MDMA - Tramadol, Linezolid, Ondansetron, St. John’s wort, Meperidine, Dextromethorphan, Triptans, and MDMA. Okay, so tramadol, meperidine, dextromethorphan, and St. John’s wort, all increase the concentration of serotonin by blocking serotonin reuptake transporters. Another medication you should think of is linezolid, which blocks monoamine oxidases and prevents them from breaking down serotonin. Next we have ondansetron, which acts as a serotonin receptor antagonist, which means that it binds and inhibits serotonin receptors on the postsynaptic membrane. As a result, serotonin can’t bind to its receptors, so it builds up throughout the central nervous system. On the flip side, triptans act as serotonin receptor agonists, so they bind and activate serotonin receptors. Finally, MDMA stimulates the presynaptic neurons to release serotonin.

Okay, to remember the most common clinical features of serotonin syndrome, think of the 3 A’s, which are autonomic effects, abnormal neuromuscular activity, and altered mental status. Autonomic effects can include gastrointestinal disturbances like diarrhea, diaphoresis or excessive sweating, mydriasis or dilated pupils, and hyperthermia or increased body temperature, as well as hypertension or elevated blood pressure, and tachycardia or increased heart rate. Abnormal neuromuscular activity may manifest as myoclonus or muscle twitching, hyperreflexia or excessive reflexes, hypertonia or increased muscle tone, tremor or involuntary shaking, and even seizures. Finally, altered mental status may present with agitation, confusion, hallucinations, or even coma.

Treatment of serotonin syndrome involves the administration of benzodiazepines and supportive care, and in severe cases administration of cyproheptadine, which can inhibit serotonin receptors.

Now, another very similar psychiatric emergency is neuroleptic malignant syndrome. Now, the exact mechanism behind neuroleptic malignant syndrome is unclear, but it seems to be associated with dopamine receptor blockade. In fact, it typically occurs in individuals taking antipsychotic medications, which remember is often used to treat schizophrenia. Most cases are caused by typical antipsychotic medications, such as haloperidol. Now, typical antipsychotics work by blocking dopamine D2 receptors, which are found in various pathways within the brain. Some high yield pathways include the mesolimbic pathway, which controls feelings of motivation, reward, and desire; the mesocortical pathway, which helps regulate emotions; and the nigrostriatal pathway, which helps control involuntary movements and coordination. Less frequently, neuroleptic malignant syndrome may be caused by atypical antipsychotics like clozapine, which can block both dopamine D2 receptors and serotonin receptors. What’s really important to note is that medications are usually not enough to develop neuroleptic malignant syndrome. In fact, there seems to be a genetic predisposition in those who have genetic variations in the gene that codes dopamine D2 receptors. And that’s a high yield fact!

Symptoms of neuroleptic malignant syndrome typically start days to weeks after starting the medications. To help you recall the most high yield symptoms, think of FEVER. F actually stands for fever or hyperthermia, and it’s one of the most characteristic symptoms of neuroleptic malignant syndrome. The first E stands for encephalopathy or brain dysfunction, which presents with an altered mental status that can range from confusion or delirium to coma. Then there’s V for vitals, which are typically unstable. This means that individuals with neuroleptic malignant syndrome may experience tachycardia, as well as a labile blood pressure that may suddenly go from normal to really high levels. Now, unstable vitals can often be associated with diaphoresis, and that’s a very high yield fact! Okay, the second E stands for enzymes, such as creatine kinase that may be elevated in blood, as well as myoglobinuria or the presence of myoglobin in urine. What’s important to note here is that these enzymes are normally found inside skeletal muscle cells, so finding them around in blood or urine typically indicates rhabdomyolysis or abnormal skeletal muscle breakdown. And what's even more important is that these enzymes can be harmful to the kidneys and often lead to acute renal failure. Finally, R stands for rigidity of muscles, which is characterized by an increased muscle tone that causes constant resistance when another person tries to move the joint of the affected individual. In a test question, this may be referred to as “lead pipe” rigidity.

Now, some of these symptoms may trick you into thinking of serotonin syndrome, so to set these two apart, remember that neuroleptic malignant syndrome tends to cause more severe hyperthermia and muscle rigidity. In addition, individuals with serotonin syndrome typically also experience mydriasis, hyperreflexia, myoclonus, and diarrhea. So be sure to keep an eye out for these clues!

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "Diagnostic and Statistical Manual of Mental Disorders" NA (1980)
  5. "Suicide prevention strategies revisited: 10-year systematic review" The Lancet Psychiatry (2016)
  6. "Psychiatric Emergencies in the Intensive Care Unit" AACN Advanced Critical Care (2015)
  7. "Neuroleptic Malignant Syndrome" American Journal of Psychiatry (2007)